2021

1. A single-run next-generation sequencing (Ngs) assay for the simultaneous detection of both gene mutations and large chromosomal abnormalities in patients with myelodysplastic syndromes (mds) and related myeloid neoplasms

   Cancers, Vol. 13, Núm. 8